AB SCIEX Expands in Singapore
News Nov 01, 2013
The facility is an extension of the company's $10-million global operations in Marsiling where life science industry-leading analytical instruments, including the AB SCIEX 6500 series and TripleTOF®series, are manufactured.
The AB SCIEX R&D Centre is focused on product development and brings R&D and manufacturing closer together. As a global leader in scientific technologies for biological and chemical analysis, AB SCIEX spends close to 10 percent of its annual revenues on R&D, which is a driving force for the company's continued innovation in LC/MS/MS (liquid chromatography/tandem mass spectrometry).
The company has also invested in an application support and training facility in the Biopolis, which is Singapore's state-of-the-art biomedical research hub housing a community of public and private researchers.
"Our significant investments in research and development, manufacturing and personnel reaffirm our commitment to Singapore as a hub for AB SCIEX global operations," said Rainer Blair, President of AB SCIEX. "As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science."
AB SCIEX joins more than 50 biotechnology and life science companies that have an R&D presence in Singapore.
"We are excited about the opening of AB SCIEX's R&D Centre in Singapore ‒ its first R&D centre outside North America. The centre will design and develop new instruments from Singapore for global markets. This is an excellent example of how leading life science tools companies such as AB SCIEX are looking to Singapore as an integrated home in Asia for complex instrument manufacturing, headquarter functions as well as R&D to support their future growth," said Ms Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board.
The company's expansion in Singapore positions AB SCIEX to better serve its customers across Asia-Pacific.
"Our proximity to Asia-Pacific customers creates greater opportunities for regional input into new products that can transform health and safety," said KY Wong, Vice President of Global Operations at AB SCIEX. "Also, by being in Singapore, we have strategic access to the Asian market's supply chain resources."
On the production side, AB SCIEX has completed the transfer of manufacturing Eksigent chromatography products from the United States to Singapore. The physical expansion of manufacturing in its Marsiling factory in northern Singapore is part of a progressive plan for the Southeast Asian manufacturing operation to take on an increased number of products.
UK Not Ready for Brexit’s Impact on Food, Report WarnsNews
Severe problems with the UK food system are likely unless issues are addressed, according to latest expert reportREAD MORE
Thermo, SRI International Collaborate to Enhance Small Molecule ResearchNews
Thermo set to collaborate with SRI International to combine results of Orbitrap LC/MS experiments with organism-specific metabolic pathway and genome data to improve small molecule research and analysis.READ MORE
One-step Protein Purification Achieves High Yields, Purity and ActivityNews
A novel method to improve the high-yield, high-purity, high-activity purification of complex proteins by 10- to 500-fold has been developed at the University of Alabama at BirminghamREAD MORE
Comments | 0 ADD COMMENT
18th International Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques
Nov 02 - Nov 03, 2017
8th Edition of International Conference on Mass Spectromerty
Mar 12 - Mar 13, 2018